Lin-Pierre ZHAO

Hematologist, MD PhD @Leukemia_institut @HopSaintLouis @Institut_IRSL

[Kelly Bolton MD PhD @KellyLBolton]

Chemotherapy and ionizing radiation are known to promote clonal hematopoiesis and its progression to leukemia. By inducing temporary quiescence of hematopoietic stem cells during external stress might we mitigate CH expansion? We address this through a collaboration with @AbdelWahablab @PuZhang09980432: https://t.co/DUExKVNRSg. Excited to share this and some thoughts from a recent meeting in Hiroshima which puts this work in a broader perspective.

[Lin-Pierre ZHAO @LinPierreZhao]

Excited to share our new article in @LeukemiaJournal on the prevalence and prognostic impact of myelodysplasia-related features in #VEXAS.
A nationwide effort from the French FRENVEX network 🇫🇷
https://t.co/WPUWBYd8ja

[Jerome HADJADJ @HadjadjJerome]

We're glad to share this article published in @Hemasphere_EHA showing that mutations in IDH (IDH1/2) can act as drivers of inflammation. https://t.co/FzIW6x12kK

[ACR_Journals @ACR_Journals]

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS - Developed by the International VEXAS Working Group Expert Panel

Figure: A practical treatment algorithm for clinical management of VEXAS syndrome based on current available evidence

[Maria Sirenko @MariaSirenko]

Thrilled to see our work out today! It’s been a joy to be a part of this incredible team! 🧬🩸

[Thibault Comont, MD @thibault_comont]

Thrilled to share our study with Vincent Jachiet and the FREnVEx group 🇫🇷on azacitidine efficacy in VEXAS syndrome, now published in @BloodJournal #VEXAS #Hematology #Azacitidine #FREnVEx #mds
https://t.co/Kh9aWbGeNZ

[Yu-Hung Wang @Wang_Yu_Hung]

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the #i4MDS consortium

https://t.co/YedhhlvgCM
@Hemasphere_EHA @KordastiL #MDSsm
@aamdsif @ic_MDS @MDS_Hub @MDSAlliance @MDSFoundation

[OncoDaily @oncodaily]

Myeloid neoplasms after MTX have features more similar to de-novo - @Anand_88_Patel (@StJude)

https://t.co/ayBx2jsWlk

@LinPierreZhao, @lihenhg, @MrinalPatnaik, @SusannaProudman

#Oncology #Cancer #Research #OncoDaily #Myeloid #Neoplasms #MTX

[Côme Bommier @ComeBommier]

Ravi de partager le post-@EHA_Hematology que nous avons fait sur invitation de Sylvie Le Gac pour Cancérologie Pratique, avec @pedrohlprata, Tristan Vaugeois et @LinPierreZhao !

Vidéo disponible jusqu'au 31/07.

https://t.co/p5hOS8cBtC

[Lin-Pierre ZHAO @LinPierreZhao]

@LabPuissant @kcw00d @MartinCNRS @lane_andy Congratulations Alex and team!!

[Alex Puissant Lab @LabPuissant]

1/ Excited to share our study with @kcw00d and @MartinCNRS on AML's dependency on PI3Kg, aligned with findings from @lane_andy and Zhao labs. It links to Venetoclax sensitivity and shows the promise of degradation over inhibition to enhance cytotoxicity. https://t.co/Izl4MMx0Q5

[Yu-Hung Wang @Wang_Yu_Hung]

Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after HMA failure in chronic myelomonocytic leukemia
https://t.co/72y9IsVTKB
#CMML #MDSsm #MPNsm

[Jerome HADJADJ @HadjadjJerome]

On this first day of the first ever #VEXAS international workshop, very happy to share our work on the Efficacy and Safety of targeted therapies in VEXAS syndrome!!
https://t.co/Vn64mqRfIz

[Vincent Alcazer @AlcazerVincent]

Our article is finally out in @LancetDigitalH

https://t.co/TNSlFV2wqW

--> Diagnosis of acute leukaemia subtypes (APL/AML/ALL) based on routine laboratory parameters using machine learning

The model is broadly available in an online-app: https://t.co/xvlvweqkLt

[Emmanuel RAFFOUX @ManuRaffoux]

Collecte d'Emmanuel Raffoux: Challenge pour la Vie https://t.co/8AAD1G5yxZ via @Alvarumfr

[Blood Journals Portfolio @BloodPortfolio]

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series
https://t.co/dDPkAJoy3a #immunobiologyandimmunotherapy #lymphoidneoplasia

[Kosmider olivier @KosmiderO]

Enfin…. Tout chaud

https://t.co/HX4Ce1zGoj

Merci @TerrierBen @FondsImmunov
@NatureComms

[François VINCENT @pr_f_vincent]

C'est la 1ère fois que j'entends un Président de la République parler aussi précisément des externes et des internes en médecine. Et il a raison. Les étudiants et les internes participent à faire tourner l'hôpital. Ils sont pleinement engagés comme soignants. Ne les oublions pas.

[Talbot Alexis @DrAlexisTalbot]

Congratulations Dr Nathalie Forgeard @HopSaintLouis @univ_paris_cite for this first paper about Teclistamab in relapsed or refractory AL amyloidosis, a multinational retrospective case series https://t.co/9cfITcLuiU #mmsm #amyloidosis @Filiere_MaRIH @AfcaContact @BloodJournal

[Nizar JOHER @JoherNizar]

Thanks to @NEJM to share our case report with this clinical images.
#nephrology #hematology

https://t.co/bic4Dr77CX